TABLE 2.
Scale score | Model 1 | Model 2 | ||||
---|---|---|---|---|---|---|
β | 95% CI | P | β | 95% CI | P | |
HAMA | −2.235 | −3.818,−0.653 | 0.006 | −2.414 | −4.455,−0.373 | 0.021 |
Somatization of anxiety | −0.952 | −1.694,−0.209 | −0.209 | −0.701 | −1.602,0.200 | 0.125 |
Body mass index(BMI) | −0.143 | −0.243,−0.042 | −0.042 | −0.149 | −0.268,−0.030 | 0.015 |
Cognitive impairment | −0.693 | −1.133,−0.252 | −0.252 | −0.182 | −0.509,0.146 | 0.273 |
Day and night | −0.065 | −0.281,0.15 | 0.018 | 0.103 | −0.201,0.407 | 0.499 |
Slow to respond | −0.801 | −1.427,−0.174 | −0.174 | −0.399 | −1.100,0.301 | 0.259 |
Sleep disorder | −0.588 | −1.061,−0.115 | −0.015 | −0.355 | −0.963,0.227 | 0.228 |
Sense of despair | −0.675 | −4.546,−3.473 | −0.016 | −0.546 | −1.051,−0.041 | 0.034 |
Physical anxiety | −0.843 | −1.627,−0.06 | −0.045 | −1.04 | −2.061,−0.019 | 0.046 |
Mental anxiety | −0.952 | −1.694,−0.209 | −0.209 | −0.701 | −1.602,0.200 | 0.125 |
HAMD | −3.450 | −5.807,−1.093 | −1.093 | −1.908 | −4.549,0.734 | 0.154 |
RPAS | 0.892 | −3.739,5.524 | 5.524 | 0.834 | −12.491,4.961 | 0.789 |
RSAS | 0.250 | −2.523,3.023 | 3.023 | −0.414 | −4.027,3.198 | 0.82 |
Using linear mixed model analyses and unstructured covariance structure to control confounding factors (baseline outcome indicators, gender, age, education level, marital status, survey season, smoking, drinking, physical activity time, sitting or lying time, BMI) at the endpoint of six months of vitamin D intervention.
Abbreviations: HAMA‐14, Hamilton Anxiety Rating Scale‐14; HAMD‐17, Hamilton Depression Rating Scale‐17; RPAS, Revised Physical Anhedonia scale; RSAS, Revised Social Anhedonia Scale.